How rilzabrutinib interacts with common drug transporters
Treatments studied
This study checks how the investigational medicine rilzabrutinib affects proteins in your body that help clear certain drugs. It helps make sure other medications you take are safe and work properly.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 55 years old
- Your weight is within a specific range (men: 110–220 lb, women: 88–198 lb)
- You are willing to use birth control during the study
- You have no history of serious infections, frequent migraines, or severe nausea/vomiting
- You have not donated blood in the last month and have no recent vaccination
- You are not currently pregnant or breastfeeding
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies how the drug risankizumab moves through your body after being given through a vein or under the skin. It helps doctors understand the best way to give the medicine to patients.
This study looks at how a medicine called rilzabrutinib (taken as a tablet) is processed in the body when the kidneys are severely damaged compared to when they work normally. It helps researchers understand if the dose needs to be adjusted for people with kidney problems.
This study looks at how two common medicines, itraconazole and rifampin, change the levels of a new drug called Rocbrutinib in healthy volunteers. The results will help doctors understand how to use Rocbrutinib safely in future patients.
This study tests an experimental pill called rilzabrutinib for people with Graves' disease, a condition where the immune system attacks the thyroid. It aims to see if the drug can help control the overactive thyroid and any related eye problems.
This study tests an oral medicine called rilzabrutinib to see if it can reduce painful episodes in people with sickle-cell disease. It may be an option if you have regular pain crises and are looking for a new treatment.
This trial tests a medication called rilzabrutinib to see if it can safely control IgG4-related disease (a condition causing inflammation in various organs) better than a placebo. It may help you reduce or stop your current steroid treatment.
Hear when a new Healthy Volunteer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.